Skip to main content

Table 1 Patient characteristics at baseline – mean (SD)

From: Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

  Losartan (n = 20) Placebo (n = 20)
  Demography
Male:Female 9:11 10:10
Age (years) 68 (8.4) 66 (7.3)
  Spirometry
FEV1 (litres) 0.85 (0.40) 0.82 (0.38)
FVC (litres) 2.5 (0.9) 2.5 (0.9)
Percent predicted FEV1 (%) 37 (19) 33 (14)
  Echo findings
TTPG (mmHg) 42.8 (8.8) 43.4 (9.9)
Estimated right atrial pressure (mmHg) 4.0 (0.8) 4.11 (0.9)
  Exercise capacity
Number of shuttles 18.3 (9.3) 18.2 (7.6)
Breathlessness score 6.4 (1.9) 6.7 (2.0)